At EPO, Patent Oppositions To High-Priced Gilead Hepatitis C Drug Pile Up27/02/2015 by Intellectual Property Watch Leave a CommentAccording to a public health advocacy group, there are now as many as 10 oppositions filed at the European Patent Office against the Gilead company’s patent on sofosbuvir, a treatment for hepatitis C. The group has compiled a table showing the filings with links to the documents.
Why The Request By Least Developed Countries For An Extension Of The Transitional Period For Granting And Enforcing Medicines Patents Needs To Be Supported27/02/2015 by Intellectual Property Watch 1 CommentEllen ‘t Hoen writes: On 24 February 2015 Bangladesh on behalf of the 34 Least Developed Country members (LDCs) of the World Trade Organization (WTO) submitted a request for an extension of the transitional period under article 66.1 TRIPS with respect to pharmaceutical products until the country is no longer classified as LDC.[1] The original extension, set to expire on 1st January 2016, specifically removes the obligation for LDCs to comply with Section 5 (Patents) and Section 7 (Protection of Undisclosed Information) of Part II of TRIPS, including any obligation to enforce rights under these provisions.It is a little known fact that since the adoption of the 2001 Doha Declaration on TRIPS and Public Health, LDCs have frequently used the extension in day-to-day procurement of low cost generic medicines, in particular to access medicines needed for the treatment of HIV.
South Africa Awaits Patent Reforms With Hope, Concern27/02/2015 by Munyaradzi Makoni for Intellectual Property Watch 4 CommentsCAPE TOWN – South Africa’s new policy on patents could go to the Cabinet for approval soon, says Doctors without Borders (Médecins Sans Frontières, MSF), one of the organisations spearheading the Fix the Patent Laws campaign in the country.
Ebola Crisis Has Severe Impact On AIDS Response In Sierra Leone, UNDP Report Says27/02/2015 by Catherine Saez, Intellectual Property Watch Leave a CommentAccording to an internal report of the United Nations Development Programme (UNDP) Global Fund Partnership team, the Ebola epidemic has virtually halted national HIV efforts in Sierra Leone. In particular, patients stopped their treatments and the supply chain was disrupted.
UK To Revamp Law On “Groundless Threats” Of Infringement Suits26/02/2015 by Dugie Standeford for Intellectual Property Watch Leave a CommentRecommendations for key reforms to laws against “groundless threats” of infringement lawsuits in patent, trademark and design rights cases won general UK government backing today. IP lawyers said the government’s stance will go far toward resolving longstanding concerns.
Tobacco Plain Packaging Discussion Lights Up Again At WTO25/02/2015 by Catherine Saez, Intellectual Property Watch 2 CommentsThe issue of plain packaging for tobacco products as a health measure has been smouldering at the World Trade Organization since Australia decided to implement legislation requiring plain packaging in 2012. Now, as more countries seek to enact similar legal provisions, some tobacco producing countries continue to try to stub them out, including at the WTO intellectual property committee.
WTO Least-Developed Countries Request Waiver Of IP Rights On Pharma Products25/02/2015 by Catherine Saez, Intellectual Property Watch 13 CommentsThis week at the World Trade Organization intellectual property committee meeting, least-developed countries submitted a request to extend a waiver allowing them not to enforce intellectual property rights on pharmaceutical products. The countries have extended the waiver before, but this time they are seeking to make it indefinite, until they are no longer considered LDCs.
New Quiet Initiative To Improve Drug Access In Middle-Income Countries, Change Country Classification System25/02/2015 by Catherine Saez, Intellectual Property Watch 2 CommentsThis week a confidential high-level expert meeting was convened in Geneva to start work on a potential change in the country classification used by global health actors to remedy the growing problem of access to medicines in middle-income countries.
Medicines Patent Pool Nails Down Another Key Paediatric Drug24/02/2015 by William New, Intellectual Property Watch Leave a CommentThe Medicines Patent Pool today announced it has struck a licence with MSD, the North American-based Merck pharmaceutical company, to boost access to and innovation on raltegravir, a child-approved HIV medicine. The outcome is particularly significant because it opens options for very young children.
WIPO Members Propose Changes To Draft Legal Instrument Protecting GIs24/02/2015 by Catherine Saez, Intellectual Property Watch 1 CommentIn the run-up to the May high-level negotiating meeting to amend a World Intellectual Property Organization treaty to enhance the protection of geographical indications, member countries were invited to suggest changes to the basic negotiating text. Ten countries issued proposed changes by the 1 February deadline, some asking for full participation of WIPO members in the negotiations of the 28-member treaty.
